A phase 1 study of a group B meningococcal native outer membrane vesicle vaccine made from a strain with deleted lpxL2 and synX and stable expression of opcA (Q84790645)

From Wikidata

Jump to navigation Jump to search

scientific article published on 21 August 2010

Language	Label	Description	Also known as
English	A phase 1 study of a group B meningococcal native outer membrane vesicle vaccine made from a strain with deleted lpxL2 and synX and stable expression of opcA	scientific article published on 21 August 2010

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20732470%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

A phase 1 study of a group B meningococcal native outer membrane vesicle vaccine made from a strain with deleted lpxL2 and synX and stable expression of opcA (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20732470%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

author name string

Paul B Keiser

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20732470%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Barnett T Gibbs

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20732470%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Trinka S Coster

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20732470%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

E Ellen Moran

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20732470%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Mark B Stoddard

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20732470%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Joseph E Labrie

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20732470%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Deborah H Schmiel

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20732470%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Valerian Pinto

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20732470%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Ping Chen

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20732470%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Wendell D Zollinger

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20732470%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

publication date

21 August 2010

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20732470%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20732470%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

28

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20732470%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

43

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20732470%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

6970-6976

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20732470%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Changes in Neisseria meningitidis disease epidemiology in the United States, 1998-2007: implications for prevention of meningococcal disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.048

7 January 2021

Meningococcal disease among United States military service members in relation to routine uses of vaccines with different serogroup-specific components, 1964-1998.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.048

7 January 2021

Three cases of invasive meningococcal disease caused by a capsule null locus strain circulating among healthy carriers in Burkina Faso

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.048

7 January 2021

Meningococcal Meningitis: Unprecedented Incidence of Serogroup X--Related Cases in 2006 in Niger

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.048

7 January 2021

Clonal analysis of the serogroup B meningococci causing New Zealand's epidemic

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.048

7 January 2021

Design and evaluation in mice of a broadly protective meningococcal group B native outer membrane vesicle vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.048

7 January 2021

Characterization of native outer membrane vesicles from lpxL mutant strains of Neisseria meningitidis for use in parenteral vaccination

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.048

7 January 2021

Modification of lipid A biosynthesis in Neisseria meningitidis lpxL mutants: influence on lipopolysaccharide structure, toxicity, and adjuvant activity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.048

7 January 2021

Evaluation of a whole-blood cytokine release assay for use in measuring endotoxin activity of group B Neisseria meningitidis vaccines made from lipid A acylation mutants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.048

7 January 2021

Characterization of an antibody depletion assay for analysis of bactericidal antibody specificity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.048

7 January 2021

Lipo-oligosaccharide immunotyping of Neisseria meningitidis by a whole-cell ELISA with monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.048

7 January 2021

The 5C protein of Neisseria meningitidis is highly immunogenic in humans and induces bactericidal antibodies.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.048

7 January 2021

Additive and synergistic bactericidal activity of antibodies directed against minor outer membrane proteins of Neisseria meningitidis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.048

7 January 2021

Properties and clinical performance of vaccines containing outer membrane vesicles from Neisseria meningitidis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.048

7 January 2021

Cross-reactivity of antibodies against PorA after vaccination with a meningococcal B outer membrane vesicle vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.048

7 January 2021

Genetically modified L3,7 and L2 lipooligosaccharides from Neisseria meningitidis serogroup B confer a broad cross-bactericidal response

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.048

7 January 2021

Lipopolysaccharide analogs improve efficacy of acellular pertussis vaccine and reduce type I hypersensitivity in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.048

7 January 2021

Differential activation of human and mouse Toll-like receptor 4 by the adjuvant candidate LpxL1 of Neisseria meningitidis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.048

7 January 2021

Distribution of Neisseria meningitidis serogroup B serosubtypes and serotypes circulating in the United States. The Active Bacterial Core Surveillance Team.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.048

7 January 2021

Nutritional profiles of Neisseria gonorrhoeae, Neisseria meningitidis, and Neisseria lactamica in chemically defined media and the use of growth requirements for gonococcal typing.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.048

7 January 2021

Identifiers

10.1016/J.VACCINE.2010.08.048

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20732470%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20732470%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q84790645&oldid=1985378491"